Countermeasures and Suggestions on Pharmaceutical Production of Drugs in the Market of Cold Medicine based on Ali Health online drug sales platform 2019 big data

Starting from the basic situation of drug use when patients treat colds. It is found that the quantity of cold cold medicine and warm cold medicine in real life is not in accordance with the epidemiological statistics. There is the possibility of unreasonable production by supplier manufacturers. The purpose of this paper is to remind suppliers that the production of drugs should be carried out according to patients’ disease conditions, so as to avoid misleading the market and thus affecting patients. From the two most important factors that affect the quantity of drugs—the supply and demand of drugs, the author makes statistics on the taste of drugs produced by manufacturers and the taste of drugs purchased by patients. It is found that the choice of cold medicine from both supply and demand is more than that of warm medicine, so it is very important for the education and guidance of manufacturers upstream of the value chain to reduce the mismatch between drug production and patient demand.

Abstract licence: CC BY

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.